The research team found medication to reduce the severity of spinal cord injury and improve long-term quality of life of the injured victim. Director of the team fears that a biopharmaceutical company, which owns the patent on the antibody used in the treatment will not continue development of the application, and it should develop a strategy to win the support of the company. If the patent owner does not choose to move forward with the treatment, the director has the ability to continue to develop themselves, but it is not satisfied that it has the business skills to do it. Students consider the ethical dilemma of balancing the need for business to make a profit for its investors with the needs of society.
This is part of a set of cases Ivey and technical notes written for the introductory-level courses. "Hide
by Elizabeth M. Grasby, David House Source: Richard Ivey School of Business Foundation 12 pages. Publication Date: February 14, 2007. Prod. #: 907M18-PDF-ENG
Related Case Solutions & Analyses:
Medical Equipment Inc. in Saudi Arabia
Inland Steel Industries (A)
Conflicting Responsibilities
Hershey
Auto Ethnogrphy
Culture Clash in the Boardroom
Honeywell and the Great Recession: The Economic Recovery (B)
Raising the Ante
Resilience at InterMune: A Journey Through the Valley of the Shadow of Death
Cipla 2011
